+1 347 708 0418
RNA-Targeted Small Molecules market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global RNA-Targeted Small Molecules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
mRNA Translation Regulation
RNA Splicing Modification
Direct RNA Targeting
Indirect RNA Targeting - Epitranscriptomics
Segment by Application
Hospitals
Laboratories
Phamacy
By Company
Accent Therapeutics
Anima Biotech Inc.
Arrakis Pharmaceuticals
Epics Therapeutics
Expansion Therapeutics
Gotham Therapeutics
H3 Biomedicine
Ribometrix
Skyhawk Therapeutics
STORM Therapeutics
Twentyeight-Seven Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 mRNA Translation Regulation
1.2.3 RNA Splicing Modification
1.2.4 Direct RNA Targeting
1.2.5 Indirect RNA Targeting - Epitranscriptomics
1.3 Market by Application
1.3.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Phamacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNA-Targeted Small Molecules Market Perspective (2017-2028)
2.2 RNA-Targeted Small Molecules Growth Trends by Region
2.2.1 RNA-Targeted Small Molecules Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 RNA-Targeted Small Molecules Historic Market Size by Region (2017-2022)
2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Region (2023-2028)
2.3 RNA-Targeted Small Molecules Market Dynamics
2.3.1 RNA-Targeted Small Molecules Industry Trends
2.3.2 RNA-Targeted Small Molecules Market Drivers
2.3.3 RNA-Targeted Small Molecules Market Challenges
2.3.4 RNA-Targeted Small Molecules Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2017-2022)
3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2017-2022)
3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2021
3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
3.7 Date of Enter into RNA-Targeted Small Molecules Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Targeted Small Molecules Breakdown Data by Type
4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2017-2022)
4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2023-2028)
5 RNA-Targeted Small Molecules Breakdown Data by Application
5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2017-2022)
5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America RNA-Targeted Small Molecules Market Size (2017-2028)
6.2 North America RNA-Targeted Small Molecules Market Size by Type
6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2017-2022)
6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2023-2028)
6.2.3 North America RNA-Targeted Small Molecules Market Share by Type (2017-2028)
6.3 North America RNA-Targeted Small Molecules Market Size by Application
6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2017-2022)
6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2023-2028)
6.3.3 North America RNA-Targeted Small Molecules Market Share by Application (2017-2028)
6.4 North America RNA-Targeted Small Molecules Market Size by Country
6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2017-2022)
6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe RNA-Targeted Small Molecules Market Size (2017-2028)
7.2 Europe RNA-Targeted Small Molecules Market Size by Type
7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2017-2022)
7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2023-2028)
7.2.3 Europe RNA-Targeted Small Molecules Market Share by Type (2017-2028)
7.3 Europe RNA-Targeted Small Molecules Market Size by Application
7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2017-2022)
7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2023-2028)
7.3.3 Europe RNA-Targeted Small Molecules Market Share by Application (2017-2028)
7.4 Europe RNA-Targeted Small Molecules Market Size by Country
7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2017-2022)
7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2017-2028)
8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2017-2022)
8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2023-2028)
8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Share by Type (2017-2028)
8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2017-2022)
8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2023-2028)
8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Share by Application (2017-2028)
8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2017-2022)
8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America RNA-Targeted Small Molecules Market Size (2017-2028)
9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2017-2022)
9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2023-2028)
9.2.3 Latin America RNA-Targeted Small Molecules Market Share by Type (2017-2028)
9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2017-2022)
9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2023-2028)
9.3.3 Latin America RNA-Targeted Small Molecules Market Share by Application (2017-2028)
9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2017-2022)
9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2017-2028)
10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2017-2022)
10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2023-2028)
10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Share by Type (2017-2028)
10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2017-2022)
10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2023-2028)
10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Share by Application (2017-2028)
10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2017-2022)
10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Accent Therapeutics
11.1.1 Accent Therapeutics Company Details
11.1.2 Accent Therapeutics Business Overview
11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.1.5 Accent Therapeutics Recent Developments
11.2 Anima Biotech Inc.
11.2.1 Anima Biotech Inc. Company Details
11.2.2 Anima Biotech Inc. Business Overview
11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.2.5 Anima Biotech Inc. Recent Developments
11.3 Arrakis Pharmaceuticals
11.3.1 Arrakis Pharmaceuticals Company Details
11.3.2 Arrakis Pharmaceuticals Business Overview
11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.3.5 Arrakis Pharmaceuticals Recent Developments
11.4 Epics Therapeutics
11.4.1 Epics Therapeutics Company Details
11.4.2 Epics Therapeutics Business Overview
11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.4.5 Epics Therapeutics Recent Developments
11.5 Expansion Therapeutics
11.5.1 Expansion Therapeutics Company Details
11.5.2 Expansion Therapeutics Business Overview
11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.5.5 Expansion Therapeutics Recent Developments
11.6 Gotham Therapeutics
11.6.1 Gotham Therapeutics Company Details
11.6.2 Gotham Therapeutics Business Overview
11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.6.5 Gotham Therapeutics Recent Developments
11.7 H3 Biomedicine
11.7.1 H3 Biomedicine Company Details
11.7.2 H3 Biomedicine Business Overview
11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.7.5 H3 Biomedicine Recent Developments
11.8 Ribometrix
11.8.1 Ribometrix Company Details
11.8.2 Ribometrix Business Overview
11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.8.5 Ribometrix Recent Developments
11.9 Skyhawk Therapeutics
11.9.1 Skyhawk Therapeutics Company Details
11.9.2 Skyhawk Therapeutics Business Overview
11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.9.5 Skyhawk Therapeutics Recent Developments
11.10 STORM Therapeutics
11.10.1 STORM Therapeutics Company Details
11.10.2 STORM Therapeutics Business Overview
11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.10.5 STORM Therapeutics Recent Developments
11.11 Twentyeight-Seven Therapeutics
11.11.1 Twentyeight-Seven Therapeutics Company Details
11.11.2 Twentyeight-Seven Therapeutics Business Overview
11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022)
11.11.5 Twentyeight-Seven Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of mRNA Translation Regulation
Table 3. Key Players of RNA Splicing Modification
Table 4. Key Players of Direct RNA Targeting
Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. Global RNA-Targeted Small Molecules Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global RNA-Targeted Small Molecules Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global RNA-Targeted Small Molecules Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global RNA-Targeted Small Molecules Market Share by Region (2017-2022)
Table 10. Global RNA-Targeted Small Molecules Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global RNA-Targeted Small Molecules Market Share by Region (2023-2028)
Table 12. RNA-Targeted Small Molecules Market Trends
Table 13. RNA-Targeted Small Molecules Market Drivers
Table 14. RNA-Targeted Small Molecules Market Challenges
Table 15. RNA-Targeted Small Molecules Market Restraints
Table 16. Global RNA-Targeted Small Molecules Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global RNA-Targeted Small Molecules Revenue Share by Players (2017-2022)
Table 18. Global Top RNA-Targeted Small Molecules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2021)
Table 19. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA-Targeted Small Molecules Product Solution and Service
Table 23. Date of Enter into RNA-Targeted Small Molecules Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2017-2022)
Table 27. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2023-2028)
Table 29. Global RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global RNA-Targeted Small Molecules Revenue Share by Application (2017-2022)
Table 31. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global RNA-Targeted Small Molecules Revenue Share by Application (2023-2028)
Table 33. North America RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America RNA-Targeted Small Molecules Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America RNA-Targeted Small Molecules Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America RNA-Targeted Small Molecules Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America RNA-Targeted Small Molecules Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe RNA-Targeted Small Molecules Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe RNA-Targeted Small Molecules Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe RNA-Targeted Small Molecules Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe RNA-Targeted Small Molecules Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific RNA-Targeted Small Molecules Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific RNA-Targeted Small Molecules Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific RNA-Targeted Small Molecules Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific RNA-Targeted Small Molecules Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America RNA-Targeted Small Molecules Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America RNA-Targeted Small Molecules Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America RNA-Targeted Small Molecules Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America RNA-Targeted Small Molecules Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa RNA-Targeted Small Molecules Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa RNA-Targeted Small Molecules Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa RNA-Targeted Small Molecules Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa RNA-Targeted Small Molecules Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa RNA-Targeted Small Molecules Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa RNA-Targeted Small Molecules Market Size by Country (2023-2028) & (US$ Million)
Table 63. Accent Therapeutics Company Details
Table 64. Accent Therapeutics Business Overview
Table 65. Accent Therapeutics RNA-Targeted Small Molecules Product
Table 66. Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 67. Accent Therapeutics Recent Developments
Table 68. Anima Biotech Inc. Company Details
Table 69. Anima Biotech Inc. Business Overview
Table 70. Anima Biotech Inc. RNA-Targeted Small Molecules Product
Table 71. Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 72. Anima Biotech Inc. Recent Developments
Table 73. Arrakis Pharmaceuticals Company Details
Table 74. Arrakis Pharmaceuticals Business Overview
Table 75. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product
Table 76. Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 77. Arrakis Pharmaceuticals Recent Developments
Table 78. Epics Therapeutics Company Details
Table 79. Epics Therapeutics Business Overview
Table 80. Epics Therapeutics RNA-Targeted Small Molecules Product
Table 81. Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 82. Epics Therapeutics Recent Developments
Table 83. Expansion Therapeutics Company Details
Table 84. Expansion Therapeutics Business Overview
Table 85. Expansion Therapeutics RNA-Targeted Small Molecules Product
Table 86. Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 87. Expansion Therapeutics Recent Developments
Table 88. Gotham Therapeutics Company Details
Table 89. Gotham Therapeutics Business Overview
Table 90. Gotham Therapeutics RNA-Targeted Small Molecules Product
Table 91. Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 92. Gotham Therapeutics Recent Developments
Table 93. H3 Biomedicine Company Details
Table 94. H3 Biomedicine Business Overview
Table 95. H3 Biomedicine RNA-Targeted Small Molecules Product
Table 96. H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 97. H3 Biomedicine Recent Developments
Table 98. Ribometrix Company Details
Table 99. Ribometrix Business Overview
Table 100. Ribometrix RNA-Targeted Small Molecules Product
Table 101. Ribometrix Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 102. Ribometrix Recent Developments
Table 103. Skyhawk Therapeutics Company Details
Table 104. Skyhawk Therapeutics Business Overview
Table 105. Skyhawk Therapeutics RNA-Targeted Small Molecules Product
Table 106. Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 107. Skyhawk Therapeutics Recent Developments
Table 108. STORM Therapeutics Company Details
Table 109. STORM Therapeutics Business Overview
Table 110. STORM Therapeutics RNA-Targeted Small Molecules Product
Table 111. STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 112. STORM Therapeutics Recent Developments
Table 113. Twentyeight-Seven Therapeutics Company Details
Table 114. Twentyeight-Seven Therapeutics Business Overview
Table 115. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product
Table 116. Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2017-2022) & (US$ Million)
Table 117. Twentyeight-Seven Therapeutics Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Targeted Small Molecules Market Share by Type: 2021 VS 2028
Figure 2. mRNA Translation Regulation Features
Figure 3. RNA Splicing Modification Features
Figure 4. Direct RNA Targeting Features
Figure 5. Indirect RNA Targeting - Epitranscriptomics Features
Figure 6. Global RNA-Targeted Small Molecules Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Laboratories Case Studies
Figure 9. Phamacy Case Studies
Figure 10. RNA-Targeted Small Molecules Report Years Considered
Figure 11. Global RNA-Targeted Small Molecules Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global RNA-Targeted Small Molecules Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global RNA-Targeted Small Molecules Market Share by Region: 2021 VS 2028
Figure 14. Global RNA-Targeted Small Molecules Market Share by Players in 2021
Figure 15. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2021
Figure 17. North America RNA-Targeted Small Molecules Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2028)
Figure 19. North America RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2028)
Figure 20. North America RNA-Targeted Small Molecules Market Size Share by Country (2017-2028)
Figure 21. United States RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe RNA-Targeted Small Molecules Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2028)
Figure 25. Europe RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2028)
Figure 26. Europe RNA-Targeted Small Molecules Market Size Share by Country (2017-2028)
Figure 27. Germany RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific RNA-Targeted Small Molecules Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific RNA-Targeted Small Molecules Market Size Share by Region (2017-2028)
Figure 37. China RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America RNA-Targeted Small Molecules Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2028)
Figure 45. Latin America RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2028)
Figure 46. Latin America RNA-Targeted Small Molecules Market Size Share by Country (2017-2028)
Figure 47. Mexico RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa RNA-Targeted Small Molecules Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa RNA-Targeted Small Molecules Market Size Share by Country (2017-2028)
Figure 53. Turkey RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE RNA-Targeted Small Molecules Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 57. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 58. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 59. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 60. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 61. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 62. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 63. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 64. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 65. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 66. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Buy
